Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
June Sherie Almenoff Insider Profile
4 Followers
June Sherie Almenoff, Director at NeuBase Therapeutics, holds 13.18K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 900.00 shares in 9 Meters Biopharma (Ticker: NMTRQ), holds 33.80K shares in NeuBase Therapeutics (Ticker: NBSE).
June Sherie Almenoff NeuBase Therapeutics (NBSE)Director
NeuBase Therapeutics (NBSE)
Director
Ranked #92,660 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-53.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of June Sherie Almenoff's holdings
Insider Roles
Roles that June Sherie Almenoff holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 08, 2019 - Jan 08, 2020
Return:+27.60%
The most profitable trade made by June Sherie Almenoff
June Sherie Almenoff's Trading History
NeuBase Therapeutics
Feb 10, 2015
Director
Informative Buy
40.50K
$13.79K
Brainstorm Cell Therapeutics
Dec 17, 2021
Director
Uninformative Buy
―
$5.67K
9 Meters Biopharma
Aug 28, 2018
COO and Chief Medical Officer
Informative Buy
6.89K
$18.00
Tenax Therapeutics
―
Director
―
―
Avalo Therapeutics
―
Director
―
―
Furiex Pharmaceuticals
Feb 06, 2014
―
Uninformative Sell
13.27M
―
List of latest transactions for each holding click on a transaction to see June Sherie Almenoff's performance on stock
You May Also Like
June Sherie Almenoff insider profile FAQ
What is the percentage of profitable transactions made by June Sherie Almenoff?
The percentage of profitable transactions made by June Sherie Almenoff is 20%.
What is the average return per transaction made by June Sherie Almenoff?
The average return per transaction made by June Sherie Almenoff is -53.00%.
What stocks does June Sherie Almenoff hold?
June Sherie Almenoff holds: NBSE, BCLI, NMTRQ, TENX, AVTX, FURX stocks.
What was June Sherie Almenoff’s latest transaction?
June Sherie Almenoff latest transaction was an Uninformative Buy of ―.
What was June Sherie Almenoff's most profitable transaction?
June Sherie Almenoff’s most profitable transaction was an Informative Buy of BCLI stock on January 8, 2019. The return on the trade was 27.60%.
What is June Sherie Almenoff's role in NeuBase Therapeutics?
June Sherie Almenoff's role in NeuBase Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.